Skip to main content
  • Home
  • COVID-19
  • Issues
    • Current Issue
    • All Issues
    • Online First
    • Supplement
    • CME
  • About
  • For Authors
    • Instructions for Authors
    • Submission Fee
    • Submit Manuscript
  • Podcasts

A Case Series of Drug-Induced Long QT Syndrome and Torsade de Pointes

< Back to Listing

Share this Article

Singapore Med J 2001; 42(12): 566-570
A Case Series of Drug-Induced Long QT Syndrome and Torsade de Pointes

  • Abstract
  • PDF

KL Tong, YS Lau, WS Teo
Correspondence: Dr W S Teo, Teo_Wee_Siong@nhc.com.sg

ABSTRACT
Introduction
 Torsade de Pointes (Tdp) is a form of polymorphic ventricular tachycardia in the setting of prolonged QT interval. Any drug that prolongs repolarisation, and hence QT interval, may cause Tdp. Predisposing factors of drug-induced Tdp include female sex, bradyarrhythmia and hypokalaemia.
Methods We retrospectively analysed the case notes of 13 patients with drug-induced LQTS from 1991 to 2000 from National Heart Centre and Changi General Hospital.
Results Causative drugs in the series were amiodarone (seven patients, 54%), sotalol (two patients), quinidine (one patient), phenothiazine (two patients) and astemizole (one patient). There were eight females and all were Chinese. The mean age was 72 +/- nine years. The patients commonly present with syncope (38%) and cardiac arrest (38%). The mean corrected QTC interval was 545 ms. The most common precipitating factor was hypokalaemia (31%). Nine patients require cardiopulmonary resuscitation and two patients (15%) died. Nine patients (69%) had underlying structural heart disease such as ischaemic heart disease, valvular heart disease and hypertensive heart disease. The left ventricular ejection fraction was normal in six patients. The onset of Tdp ranged from Day 2 to Day 5 in the seven patient with amiodarone-induced LQTS. These were inpatients who were given intravenous loading doses of amiodarone. Both patients with sotalol-induced LQTS were females on sotalol 80 mg and 240 mg per day with Tdp occurring on Day 2 and 10 months respectively.
Conclusion Tdp is a potentially life-threatening arrhythmia. The list of torsadogenic drugs is ever expanding. Physicians need to know the drugs which can lead to Tdp. Careful assessment of risk-benefit ratio is important before prescribing such drugs. Amiodarone-induced Tdp is not uncommon in our local population. Initiation of a class III agent, especially amiodarone, should be done judiciously, with monitoring of the QT interval and avoidance of hypokalaemia.

Keywords: drug-induced long-QT syndrome, Torsade de Pointes, class III agent, torsadogenic drugs
Singapore Med J 2001; 42(12): 566-570

http://smj.org.sg/sites/default/files/4212/4212a5.pdf
×
POPULAR THIS MONTH
Primary care approach to Kawasaki disease
SingHealth Radiology Archives pictorial essay Part 2: gastroenterology, musculoskeletal, and obstetrics and gynaecology cases
Are migrant workers in Singapore receiving adequate healthcare? A survey of doctors working in public tertiary healthcare institutions
Health-seeking behaviour of the elderly living alone in an urbanised low-income community in Singapore

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.